Publications by authors named "G Kalamaras"
The present study investigated the fate, and the biological effects posed by the presence of Disposable Face Masks (DFMs) into fresh- and saltwater media, using both chemical and biological testing. To this end, slightly fragmented DFMs were maintained in tanks with artificial sea water (ASW) or dHO (DFMASW and DFMdHO, respectively) for a period of 20 days (under continuous agitation, oxygen supply, and light/dark ration 1:1) to simulate both fresh- and saltwater natural conditions. Thereafter, DFMs leaching substances were determined, before proceeding to biological testing with the use of the marine bacterium Aliivibrio fischeri (Bioluminescence Inhibition assay), the fresh- and saltwater algal species Chlorococcum sp.
View Article and Find Full Text PDFArticle Synopsis
- Tobacco smoking increases the risk of cardiovascular diseases (CVD) and is linked to obstructive sleep apnea (OSA), both of which contribute to significant health issues.
- There is limited research on how pharmacotherapy for smoking cessation, like nicotine replacement therapy (NRT), bupropion, and varenicline, impacts OSA and cardiovascular health, with some studies showing mixed results.
- Personalized treatment is crucial for smokers with OSA during cessation attempts, and more research is needed to assess the effectiveness and safety of smoking cessation medications in this population.
The connection between smoking and Obstructive sleep apnea (OSA) is not yet clear. There are studies that have confirmed the effect of smoking on sleep disordered breathing, whereas others did not. Nicotine affects sleep, as smokers have prolonged total sleep and REM latency, reduced sleep efficiency, total sleep time, and slow wave sleep.
View Article and Find Full Text PDF: Studies have tried to establish a relationship between Obstructive Sleep Apnea syndrome (OSA) and smoking but data still remain controversial. We aimed: 1. To evaluate the relationship between smoking and OSA; 2.
View Article and Find Full Text PDFObjective/background: Varenicline (VAR) is used for smoking cessation as it inhibits nicotine for binding on its receptors reducing nicotine dependence. VAR administration has been reported to affect sleep. The aim of this study was to evaluate possible changes in polysomnography (PSG) during VAR treatment (SmokeFreeBrain) in healthy smokers and smokers with obstructive sleep apnea (OSA).
View Article and Find Full Text PDF